tradingkey.logo
搜尋

Clearpoint Neuro Inc

CLPT
添加自選
14.940USD
+0.360+2.47%
收盤 07-31 16:00美東報價延遲15分鐘
448.04M總市值
虧損本益比TTM

關於 Clearpoint Neuro Inc 公司

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Clearpoint Neuro Inc簡介

公司代碼CLPT
公司名稱Clearpoint Neuro Inc
上市日期Jul 03, 2019
CEOBurnett (Joseph Michael)
員工數量115
證券類型Ordinary Share
年結日Jul 03
公司地址120 S. Sierra Avenue
城市SOLANA BEACH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92075
電話19499006833
網址https://www.clearpointneuro.com/
公司代碼CLPT
上市日期Jul 03, 2019
CEOBurnett (Joseph Michael)

Clearpoint Neuro Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
311.43K
+0.44%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.54K
+0.25%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
311.43K
+0.44%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.54K
+0.25%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

常見問題

Clearpoint Neuro Inc的前五大股東是誰?

Clearpoint Neuro Inc的前五大股東如下:Mr. Joseph Michael Burnett

有多少機構持有Clearpoint Neuro Inc(CLPT)的股份?

截至2026Q1,共有266家機構持有Clearpoint Neuro Inc的股份,合計持有的股份價值約為15.83M,占公司總股份的52.78% 。與2025Q4相比,機構持股有所增加,增幅為1860542.00。

哪個業務部門對Clearpoint Neuro Inc的收入貢獻最大?

在2026Q1,Products: Functional neurosurgery業務部門對Clearpoint Neuro Inc的收入貢獻最大,創收14.83M,占總收入的40.12% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有